Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a 50-year-old antipsychotic drug shrink hard-to-treat small cell cancers?

NCT ID NCT07206563

Not yet recruiting Disease control Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 31 times

Summary

This study tests penfluridol, a drug originally used for mental health, in 33 adults with advanced small cell lung or cervical cancer that has not responded to at least two prior treatments. The goal is to find a safe weekly dose and see if it can shrink tumors. Penfluridol is taken by mouth and may work by blocking a specific signal that helps these cancer cells grow.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER (SCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

SMALL CELL CARCINOMA SMALL CELL CARCINOMA OF LUNG SMALL CELL CERVICAL CARCINOMA SMALL CELL LUNG CANCER (SCLC) SMALL CELL LUNG CANCER (SCLC)